Form of Award NoticeAmgen Inc • April 30th, 2014 • Biological products, (no disgnostic substances) • Delaware
This notice of Award (the “Award Notice”) sets forth certain details relating to the grant by the Company to you of the Award identified below, pursuant to the Plan. The terms of this Award Notice are incorporated into the Agreement that accompanies this Award Notice and made part of the Agreement. Capitalized terms used in this Award Notice that are not otherwise defined in this Award Notice have the meanings given to such terms in the Agreement.
Form of Award NoticePerformance Unit Agreement • April 30th, 2014 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
This notice of Award (the “Award Notice”) sets forth certain details relating to the grant by the Company to you of the Award identified below, pursuant to the Plan. The terms of this Award Notice are incorporated into the Agreement that accompanies this Award Notice and made part of the Agreement. Capitalized terms used in this Award Notice that are not otherwise defined in this Award Notice have the meanings given to such terms in the Agreement.
TO THE SHAREHOLDERS’ AGREEMENT OF KIRIN-AMGEN, INC.Shareholders’ Agreement • April 30th, 2014 • Amgen Inc • Biological products, (no disgnostic substances) • California
This AMENDMENT NO. 14 TO THE SHAREHOLDERS’ AGREEMENT OF KIRIN-AMGEN, INC., dated as of March 26, 2014 (this “Amendment Agreement”), is made and entered into by and among Kirin Holdings Company, Limited, a Japanese corporation (“Kirin Holdings”), Kyowa Hakko Kirin Co., Ltd., a Japanese corporation (“KHK”), Amgen Inc., a Delaware corporation (“Amgen”), and Kirin-Amgen, Inc., a Delaware corporation (“Kirin-Amgen”). All capitalized terms used in this Amendment Agreement and not otherwise defined herein shall have the meanings assigned to such terms in the Shareholders’ Agreement (defined below), as amended hereby.
